Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Cancer: early-phase trial registry
279 of 621 indexed Cancer trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #6 of 28,963 conditions by registered trial count.
621 US clinical trials · 279 currently recruiting · #6 of 28,963 conditions by registered trial count
Cancer: 621 US clinical trials tracked, 279 recruiting.
Cancer is the subject of 621 registered US clinical trials on ClinicalTrials.gov, 279 of them currently open to new participants. 31 are in Phase 3-4 (later-stage) and 164 in Phase 1-2 (earlier-stage). The most active sponsor is M.D. Anderson Cancer Center, running 31 of these trials.
Open enrollment, early-phase tilt
Cancer has 621 registered US clinical trials, 279 of them open to new participants right now, about 45% of the total.
- 279
- recruiting participants now
- 45%
- of trials open to enrollment
- 31
- in Phase 3-4 (later-stage)
- 31
- top sponsor: M.D. Anderson Cancer Center
Corpus placement: #6 of 28,963 conditions by registered trial count on ClinicalTrials.gov-derived indexes. Registry reference only, not medical advice.
Key findings
What ClinicalTrials.gov does not surface for Cancer on its own pages , computed from the registry mirror as of 2026-07-11. Each line carries its own denominator so it can be quoted as it stands.
-
Cancer is recruiting above its size-band peers.
279 of 621 indexed trials (44.9%) are open to enrollment, against a 37.2% average across 135 conditions with 100+ trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
Sponsorship of Cancer trials is spread across many organizations.
M.D. Anderson Cancer Center accounts for 31 of 621 trials (5%). 270 distinct sponsors appear on at least one study for this condition label.
-
Typical Cancer enrolment sits around 108 participants.
Median target enrolment is 108 among the 616 trials that report a genuine target (sentinel values excluded). 287 of those (46.6%) plan for fewer than 100 participants.
-
Cancer research is mostly interventional.
462 interventional and 159 observational studies make up this index (74.4% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
621 total, page 2 of 13
Quality of Life (QoL) Assessment in Cancer Patients and Survivors With Dermatologic Conditions Using Dermatologic QoL Instruments
Memorial Sloan Kettering Cancer Center
NCT02296450
A Decisional Intervention for Older Adults With Acute Myeloid Leukemia and Their Caregivers
University of Rochester
NCT06697600
Association Between Exercise, Patient-Reported Outcomes, and Clinical Events in Adult Cancer Survivors
Memorial Sloan Kettering Cancer Center
NCT07030686
Cannabis Use Registry to Improve Overall Understanding of Symptoms (CURIOUS)
HealthPartners Institute
NCT07227324
Precision Cancer Medicine for Advanced Cancer Through High-throughput Sequencing
Ohio State University Comprehensive Cancer Center
NCT02090530
eHealth Delivery Alternative for Cancer Genetic Testing for Hereditary Cancer
Abramson Cancer Center at Penn Medicine
NCT05427240
Prevent Cancer- Greenville
Prisma Health-Upstate
NCT04947098
DOAC - Dosing Options in AntiCoagulation Prophylaxis
University of Vermont
NCT07005024
GC-PRO Intervention
University of Minnesota
NCT06671704
Post-Discharge Risk-Based Management in Patients Undergoing High-Risk Elective Major Cancer Operations (PRS II)
Fox Chase Cancer Center
NCT05454280
Spiritual Care or Psychotherapy Versus Palliative Care Alone in Patients With Non-Curative Malignancies
The Methodist Hospital Research Institute
NCT07290491
Occupational Cancer Screening in Firefighters: A Pilot Study Within the Inova Health System
Inova Health Care Services
NCT06931561
Study of the Effect of Innate on the Inflammatory Response to Endotoxin
National Institute of Environmental Health Sciences (NIEHS)
NCT01143480
Met Non Small Cell Cancer Registry (MOMENT)
EMD Serono Research & Development Institute
NCT05376891
Immune Reconstitution in Stem Cell Transplant Recipients
University of Miami
NCT02129543
Evaluation of Late Effects and Natural History of Disease in Patients Treated With Radiotherapy
National Cancer Institute (NCI)
NCT00026650
Patient-Centered Assessment of Symptoms and Outcomes
National Center for Complementary and Integrative Health (NCCIH)
NCT03952624
Effectiveness of Central Oncology Navigation and the Use of an ORN
UNC Lineberger Comprehensive Cancer Center
NCT06618274
Modernizing Instructions to Improve Treatment Participation of Subjects During Their First Radiotherapy
University of Florida
NCT06246409
Autoimmunity After Checkpoint Blockade
Abramson Cancer Center at Penn Medicine
NCT04119713
Cannabis Use and Outcomes in Black and White Patients With Cancer
State University of New York at Buffalo
NCT06037681
FOG-001 in Locally Advanced or Metastatic Solid Tumors
Parabilis Medicines
NCT05919264
Re-Engaging AYA Survivors in Cancer-Related Healthcare
Children's Hospital of Philadelphia
NCT07138040
Understanding Patient Experience Among Asians at MD Anderson
M.D. Anderson Cancer Center
NCT06259253
NOURISH-T+: Promoting Healthy Eating and Exercise Behaviors
University of South Florida
NCT04656496
Implement and Test Visual Consent Template and Process
Washington University School of Medicine
NCT06804837
Addressing Tetrachloroethylene Exposure in an Impacted Community
Purdue University
NCT05819996
Ovarian Tissue Cryopreservation for Fertility Preservation
University of Pittsburgh
NCT05875155
Intra- and Inter-fraction Changes in Radiation Therapy
Medical College of Wisconsin
NCT02344121
Rare Tumors and Cancer Predisposition in Individuals and Families
National Cancer Institute (NCI)
NCT05350761
TEMPUS ARIES: A Biobank Registry Platform Study in Oncology
Tempus AI
NCT06207032
The ECOG-ACRIN SUPPORT Trial: Multilevel Intervention to Improve Diverse Enrollment in Cancer Clinical Trials
Eastern Cooperative Oncology Group
NCT06756607
UNC Childhood, Adolescent, and Young Adult Cancer Cohort
UNC Lineberger Comprehensive Cancer Center
NCT05096923
Multi-Cancer Detection Observational Cohort Study
Mayo Clinic
NCT06962995
Evaluation of Non-Invasive Assays for the Detection of Urothelial Cancer
Lahey Clinic
NCT00872495
Prospective Data Registry and Quality of Life Assessment of Patients Undergoing Radiotherapy With the RefleXion Medical Radiotherapy System
RefleXion Medical
NCT05406167
From Screening to Support: A Multi-Method Analysis of HRSN Integration in Cancer Care
Thomas Jefferson University
NCT07352579
A New Psychotherapy Intervention for Older Cancer Patients
Memorial Sloan Kettering Cancer Center
NCT04452825
An Internet-based Program to Help Cancer Survivors Manage Pain
Wake Forest University Health Sciences
NCT04462302
IMmunotherapy: Prospective Assessment of Cannabis Treatment in Cancer
State University of New York at Buffalo
NCT06206941
Exploring Mindsets, Beliefs and Resilience Across the Cancer Experience
Stanford University
NCT06705218
Observational Basket Trial to Collect Tissue to Develop and Train a Live Tumor Diagnostic Platform
Elephas
NCT05520099
Evaluation of Grief Therapy Approaches for Bereaved Parents
University of Miami
NCT05142605
Study to Continue Treatment With Darolutamide in Patients Who Have Been Participating in Previous Darolutamide Studies Supported by Bayer
Bayer
NCT04464226
Risk Factors, Clinical Characteristics and Outcomes of Acute Infection With Coronavirus 2019 (COVID-19) In Children
St. Jude Children's Research Hospital
NCT04371315
Investigation of Profile-related Evidence Determining Individualized Cancer Therapy for Patients With Aggressive Malignancies and Poor Prognoses
Medical College of Wisconsin
NCT05674825
Psycho-Spiritual Management for Patients With Advanced Cancer and Their Family Caregivers
M.D. Anderson Cancer Center
NCT06409065
Abatacept in Immune Checkpoint Inhibitor Myocarditis
Massachusetts General Hospital
NCT05335928
Phase I Study of SYS6043 in Patients With Advanced/Metastatic Solid Tumors
Conjupro Biotherapeutics
NCT07424547
Promoting Access, Resources and Treatment Through Novel and Equitable Solutions for Cancer Care
Case Comprehensive Cancer Center
NCT06481774
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 116 |
| Phase 2 | 48 |
| Phase 3 | 27 |
| Phase 4 | 4 |
Top Sponsors
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
What is open for Cancer right now
279 recruiting of 621 indexed (45% open).
Phase mix: 31 late (III/IV) vs 164 early (I/II) (early-phase heavy).
Top sponsor: M.D. Anderson Cancer Center (31 trials), 9 others listed. 50 shown below, recruiting first. #6 of 28,963 conditions by registered trial count.
How open-enrollment share is computed
Open share is recruiting_count divided by trial_count for this condition label in the public registry export. Status can change between pulls; treat the figure as a snapshot of research attention, not treatment availability.
Frequently Asked Questions
How many clinical trials are there for Cancer?
PlainTrial tracks 621 US clinical trials for Cancer, of which 279 are currently recruiting participants. Data sourced from ClinicalTrials.gov.
How do I find a recruiting trial for Cancer?
Use the trial list above filtered by "Recruiting" status, or visit our trial finder at /recruiting to search by condition and state. Always discuss trial participation with your healthcare provider before enrolling.
Is this data current?
Data is sourced from ClinicalTrials.gov and reflects our most recent data pull. Trial status may have changed since then. Always verify current information at ClinicalTrials.gov before making decisions about participation.
Related
Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from ClinicalTrials.gov (National Library of Medicine). Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Source: ClinicalTrials.gov (NIH/NLM) ClinicalTrials.gov AACT registry · 2026 Trial counts and statuses sourced from ClinicalTrials.gov. Sponsor counts include both industry and federal/academic sponsors.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page aggregates every registered trial for this condition, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.